Breakthrough in enzyme communication could pave the way for new drugs

FHS
June 20, 2024
7:15 pm

A mechanism that could help scientists harness enzymes for use in drug discovery has been discovered in a research breakthrough at the University of Birmingham.

Health Canada approves FYB201/Ranopto® (Ranibizumab), a biosimilar to Lucentis® – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Approval Health Canada approves FYB201/Ranopto® (Ranibizumab), a biosimilar to Lucentis® 07.12.2023 / 07:30 CET/CEST The issuer is solely

December 8, 2023

No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh In

AMSTERDAM — Two trials from Asia weighed in on reducing components and duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) but with

August 30, 2023

A deeper look at COVID-19 transmission and fetal health

A new Cleveland Clinic-led study published in The EMBO Journal shows that mild and asymptomatic SARS-CoV-2 infections can trigger immune responses in a pregnant individual

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.